Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Monitoring cellular immune responses to cancer immunotherapy
M A Morse, T M Clay, A C Hobeika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Assays for monitoring cellular immune responses to active immunotherapy of cancer
T M Clay, A C Hobeika, P J Mosca, et al.
Cancer Research
|
August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells
S L Kominsky, A C Hobeika, F A Lake, et al.
International Journal of Cancer
|
December 18, 2001
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer
S L Kominsky, B A Torres, A C Hobeika, et al.
Expert Opinion on Biological Therapy
|
March 22, 2007
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
Benjamin F Johnson, Timothy M Clay, Amy C Hobeika, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 3, 2011
Depletion of human regulatory T cells
Amy C Hobeika, Michael A Morse, Takuya Osada, et al.
Oncogene
|
January 9, 1999
IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1
S Kominsky, H M Johnson, G Bryan, et al.
Journal of Visceral Surgery
|
May 9, 2020
Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery
M Luong-Nguyen, H Hermand, S Abdalla, et al.
Journal De Chirurgie Viscerale
|
April 29, 2020
[Nosocomial infection with SARS-Cov-2 within departments of digestive surgery]
M Luong-Nguyen, H Hermand, S Abdalla, et al.
Current Opinion in Molecular Therapeutics
|
April 3, 2003
Proteomics for monitoring immune responses to cancer vaccines
Paul J Mosca, H Kim Lyerly, C Denise Ching, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Monitoring cellular immune responses to cancer immunotherapy
M A Morse, T M Clay, A C Hobeika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Assays for monitoring cellular immune responses to active immunotherapy of cancer
T M Clay, A C Hobeika, P J Mosca, et al.
Cancer Research
|
August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells
S L Kominsky, A C Hobeika, F A Lake, et al.
International Journal of Cancer
|
December 18, 2001
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer
S L Kominsky, B A Torres, A C Hobeika, et al.
Expert Opinion on Biological Therapy
|
March 22, 2007
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
Benjamin F Johnson, Timothy M Clay, Amy C Hobeika, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 3, 2011
Depletion of human regulatory T cells
Amy C Hobeika, Michael A Morse, Takuya Osada, et al.
Oncogene
|
January 9, 1999
IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1
S Kominsky, H M Johnson, G Bryan, et al.
Journal of Visceral Surgery
|
May 9, 2020
Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery
M Luong-Nguyen, H Hermand, S Abdalla, et al.
Journal De Chirurgie Viscerale
|
April 29, 2020
[Nosocomial infection with SARS-Cov-2 within departments of digestive surgery]
M Luong-Nguyen, H Hermand, S Abdalla, et al.
Current Opinion in Molecular Therapeutics
|
April 3, 2003
Proteomics for monitoring immune responses to cancer vaccines
Paul J Mosca, H Kim Lyerly, C Denise Ching, et al.
Page
of 6